Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs RCAT✓SelectedUSD · RCATMRNA vs RCAT performance historyLatest closeAs of-3.93%11/17
Stock and ETF performance explorer

MRNA vs RCAT

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+170.5%
RCAT return
+177.0%
Excess return
-6.5%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioRCATExcessAlpha
1D-3.9%-31.7%+27.8%-1.2%
7D-17.6%-42.8%+25.2%-13.9%
30D-5.1%-48.9%+43.8%-0.3%
3M+220.8%-76.9%+297.7%+257.7%
6M+321.7%-74.6%+396.3%+361.8%
YTD+601.3%-69.6%+670.9%+649.4%
1Y+735.2%-64.4%+799.6%+781.7%
3Y+170.5%+173.9%-3.3%+162.2%
All+170.5%+177.0%-6.5%+162.2%

Cumulative growth

Daily Returns

Daily percentage return beside RCAT.

Daily Out/Under-Performance

Portfolio return minus RCAT return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RCAT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded RCAT wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling